Employee Benefit Plans (Tables)

9 Months Ended

Mar. 31, 2020

Share Based Compensation [Abstract]

Shares Reserved for Issuance

The Company had reserved for issuance as of the dates noted (in thousands):

	March 31, 2020		June 30, 2019
2013 Equity Incentive Plan shares available for grant		11,368		8,462
Employee stock options and awards outstanding		12,086		10,455
2014 Employee Stock Purchase Plan		7,364		10,085
Total shares reserved for issuance		30,818		29,002

Schedule of Recognized Share-based Compensation Expense

Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line item caption is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	March 31, 2020		March 31, 2019		March 31, 2020		March 31, 2019
Cost of product revenue	$	280	$	223	$	932	$	618
Cost of service revenue		368		648		1,220		1,670
Research and development		2,518		2,814		8,213		7,953
Sales and marketing		1,338		3,187		8,568		8,529
General and administrative		2,639		1,942		7,523		5,569
Integration costs		—		—		479		—
Total share-based compensation expense	$	7,143	$	8,814	$	26,935	$	24,339

Summary of Stock Award Activity

The following table summarizes stock award activity for the nine months ended March 31, 2020 (in thousands, except grant date fair value):

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Market Value
Non-vested stock awards outstanding at June 30, 2019		7,736		$	7.67
Granted		6,299			6.83
Released		(3,365	)		7.11
Cancelled		(1,598	)		7.28
Non-vested stock awards outstanding at March 31, 2020		9,072		$	7.40	$	28,033
Vested and expected to vest at March 31, 2020		6,397		$	7.26	$	25,947

Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended March 31, 2020 (in thousands, except per share and contractual term):

	Number of Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2019		2,719		$	4.61		3.26	$	5,070
Granted		637			6.70
Exercised		(217	)		4.58
Cancelled		(125	)		6.02
Options outstanding at March 31, 2020		3,014		$	4.99		3.39	$	524
Vested and expected to vest at March 31, 2020		3,014		$	4.99		3.39	$	524
Exercisable at March 31, 2020		1,693		$	3.78		1.43	$	524

Schedule of Fair Value Assumptions for Stock Options and Employee Stock Purchase Plan Awards

The following assumptions were used to calculate the fair value of shares issued under the ESPP during the following periods:

	Employee Stock Purchase Plan						Employee Stock Purchase Plan
	Three Months Ended						Nine Months Ended
	March 31, 2020			March 31, 2019			March 31, 2020			March 31, 2019
Expected life	0.5 years			0.5 years			0.5 years			0.5 years
Risk-free interest rate		1.56	%		2.46	%		1.71	%		2.35	%
Volatility		43	%		75	%		43	%		70	%
Dividend yield		—	%		—	%		—	%		—	%